Palvella Therapeutics, Inc. Other Revenue, Net (Deprecated 2018-01-31)
Palvella Therapeutics, Inc. (PVLA) reported Other Revenue, Net (Deprecated 2018-01-31) of $91.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2019-03-18
- Palvella Therapeutics, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-12-31 was $0.00.
- Palvella Therapeutics, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Palvella Therapeutics, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $0.00.
- Palvella Therapeutics, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $91.00K.
- Palvella Therapeutics, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2018 was $91.00K, a 550.00% increase from fiscal 2017.
- Palvella Therapeutics, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2017 was $14.00K.
- Palvella Therapeutics, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Palvella Therapeutics, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $18.44K.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $91.00K 10-K · filed 2019-03-18 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $91.00K 10-Q · filed 2018-11-07 | $91.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | $91.00K 10-Q · filed 2018-08-09 | $91.00K derived: sum of 3 quarters · filed 2019-03-18 | $105.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2018-03-31 | $91.00K 10-Q · filed 2018-05-10 | $91.00K derived: sum of 2 quarters · filed 2019-03-18 | $105.00K derived: sum of 3 quarters · filed 2019-03-18 | $105.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $14.00K derived: sum of 2 quarters · filed 2019-03-18 | $14.00K derived: sum of 3 quarters · filed 2019-03-18 | $14.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | $14.00K 10-Q · filed 2018-11-07 | $14.00K derived: sum of 2 quarters · filed 2018-11-07 | $14.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-15 | |||
| 2015-12-31 | $18.44K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |